Download integrale PDF - Progetto Mondiale Asma - Ginasma

97. Simons FE. A comparison of beclomethasone,
salmeterol, and placebo in children with asthma.
Canadian Beclomethasone Dipropionate-Salmeterol
Xinafoate Study Group.
N Engl J Med 1997; 337: 1659-65.
98. Lemanske RF Jr, Sorkness CA, Mauger EA, Lazarus
SC, Boushey HA, Fahy JV, et al. Inhaled corticosteroid
reduction and elimination in patients with persistent
asthma receiving salmeterol: a randomized controlled
trial. JAMA 2001; 285: 2594-603.
99. Lazarus SC, Boushey HA, Fahy JV, Chinchilli VM,
Lemanske RF Jr, Sorkness CA, et al. Long-acting β 2 -
agonist monotherapy vs continued therapy with inhaled
corticosteroids in patients with persistent asthma: a
randomized controlled trial. JAMA 2001; 285: 2583-93.
100. Malmstrom K, Rodriguez-Gomez G, Guerra J,
Villaran C, Pineiro A, Wei LX, et al. Oral montelukast,
inhaled beclomethasone, and placebo for chronic
asthma. A randomized, controlled trial.
Montelukast/Beclomethasone Study Group.
Ann Intern Med 1999; 130: 487-95.
101. Hall IP. Pharmacogenetics of asthma.
Eur Respir J 2000; 15: 449-51.
102. Anderson SD, Rozea PJ, Dolton R, Lindsay DA.
Inhaled and oral bronchodilator therapy in exercise
induced asthma. Aust N Z J Med 1975; 5: 544-50.
103. Shaw RJ, Waller JF, Hetzel MR, Clark TJ. Do oral and
inhaled terbutaline have different effects on the lung?
Br J Dis Chest 1982; 76: 171-6.
104. Cates CJ, Rowe BH. Holding chambers versus
nebulisers for beta-agonist treatment of acute asthma.
Cochrane Database Syst Rev 2000; 2.
105. Bisgaard H. A metal aerosol holding chamber devised
for young children with asthma.
Eur Respir J 1995; 8: 856-60.
106. Brown PH, Greening AP, Crompton GK. Large volume
spacer devices and the influence of high dose
beclomethasone dipropionate on hypothalamo-pituitaryadrenal
axis function. Thorax 1993; 48: 233-8.
107. Newhouse MT. Emergency department management of
life-threatening asthma. Are nebulizers obsolete?
Chest 1993; 103: 661-3.
108. Turner MO, Patel A, Ginsburg S, FitzGerald JM.
Bronchodilator delivery in acute airflow obstruction.
A meta-analysis. Arch Intern Med 1997; 157: 1736-44.
109. Langley PC. The technology of metered-dose inhalers
and treatment costs in asthma: a retrospective study of
breath actuation versus traditional press-andbreathe
inhalers. Clin Ther 1999; 21: 236-53.
158 PROGRAMMA DI TRATTAMENTO DELL’ASMA IN SEI PARTI
110. Giannini D, Di Franco A, Bacci E, Dente FL, Taccola M,
Vagaggini B, Paggiaro PL. The protective effect of
salbutamol using different devices on methacholine
bronchoconstriction. Chest 117: 1319-1323, 2000.
111. Newman SP. A comparison of lung deposition patterns
between different asthma inhalers.
J Aerosol Med 1995; 8 Suppl 3: 21-6S.
112. Dolovich M. New delivery systems and propellants.
Can Respir J 1999; 6: 290-5.
113. Leach CL, Davidson PJ, Boudreau RJ. Improved airway
targeting with the CFC-free HFA-beclomethasone
metered-dose inhaler compared with
CFCbeclomethasone. Eur Respir J 1998; 12: 1346-53.
114. Harrison LI, Soria I, Cline AC, Ekholm BP.
Pharmacokinetic differences between
chlorofluorocarbon and chlorofluorocarbon-free metered
dose inhalers of beclomethasone dipropionate in adult
asthmatics. J Pharm Pharmacol 1999; 51: 1235-40.
115. Woodcock A, Williams A, Batty L, Masterson C,
Rossetti A, Cantini L. Effects on lung function,
symptoms, and bronchial hyperreactivity of low-dose
inhaled beclomethasone dipropionate given with HFA-
134a or CFC propellant.
J Aerosol Med. 2002 ; 15: 407-414.
116. Wilson JW, Djukanovic R, Howarth PH, Holgate ST.
Inhaled beclomethasone dipropionate downregulates
airway lymphocyte activation in atopic asthma.
Am J Respir Crit Care Med 1994; 149: 86-90.
117. Olivieri D, Chetta A, Del Donno A, Bertorelli G, Casalini
A, Pesci A, Testi R, Foresi A. Effect of short-term
treatment with low-dose inhaled fluticasone propionate
on airway inflammation and remodeling in mild asthma:
a placebo-controlled study.
Am J Respir Crit Care Med 1997; 155: 1864-1871.
118. Chetta A, Zanini A, Foresi A, Del Donno M, Castagnaro
A, D’Ippolito R, Baraldo S, Testi R, Saetta M, Olivieri D.
Vascular component of airway remoeling in asthma is
reduced by high dose of fluticasone.
Am J Respir Crit Care Med 2003; 167: 751-757.
119. The Childhood Asthma Managment Program Research
Group. Long term effects of budesonide or nedocromil in
children with asthma. N Engl J Med 2000; 343: 1054-63.
120. Suissa S, Ernst P, Benayoun S, Baltzan M, Cai B. Lowdose
inhaled corticosteroids and the prevention of death
from asthma. N Engl J Med 2000; 343: 332-6.
121. Martin RJ, Szefler SJ, Chinchilli VM, Kraft M, Dolovich
M, Boushet HA, Cherniack RM, Craig TJ, Drazen JM, et
al. Systemic effect comparisons of six inhaled
corticosteroid preparations.
Am J Respir Crit Care Med 2002; 165: 1377-1383.